Symbiotic Use in Post-Bariatric Surgery Patients

Description

The purpose of this double blind, randomized control trial would be to test the efficacy of a once daily, multi strain symbiotic on gut health changes in weight loss surgery patients by testing stool samples prior to administration and then three months post administration of the symbiotic to monitor any changes in bacteria in the stool samples. Study participants will also complete a survey that evaluates their bowel habits, stool consistency, and gastrointestinal related symptoms.

Conditions

Bariatric Surgery Candidate

Study Overview

Study Details

Study overview

The purpose of this double blind, randomized control trial would be to test the efficacy of a once daily, multi strain symbiotic on gut health changes in weight loss surgery patients by testing stool samples prior to administration and then three months post administration of the symbiotic to monitor any changes in bacteria in the stool samples. Study participants will also complete a survey that evaluates their bowel habits, stool consistency, and gastrointestinal related symptoms.

Do Symbiotics Provide Helpful Benefits in Gastrointestinal Related Issues in Weight Loss Surgery Patients?

Symbiotic Use in Post-Bariatric Surgery Patients

Condition
Bariatric Surgery Candidate
Intervention / Treatment

-

Contacts and Locations

Jacksonville

University of North Florida, Jacksonville, Florida, United States, 32224

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 12 months or greater post malabsorptive weight loss procedure
  • * LapBand or Intra-gastric balloon patients due to lack of surgical alteration to gut
  • * Individuals who have not had an approved weight loss procedure
  • * Individuals with impaired gastrointestinal function which would impair ingestion of oral supplement
  • * Individuals with impaired gastrointestinal function which would impair ability to collect stool sample
  • * Inability to comprehend and complete assessment tools
  • * Inability to adhere to 90-day capsule supplement administration
  • * Currently taking daily probiotic, prebiotic, or symbiotic supplement
  • * Currently taking antibiotic treatment from physician

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of North Florida,

Study Record Dates

2024-12